UroGen Pharma Ltd. URGN
NASDAQ · United States · Health Technology
$40.84+0.21 (+0.52%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.28 | -0.27 | -5.7% | $72.46M | +14.0% | +14.2%$39.92→$45.60 |
| Q1 2026 | 2026-05-06 | -0.47 | -0.56 | +16.1% | — | — | +11.6%$23.83→$26.59 |
| Q4 2025 | 2026-03-02 | -0.53 | -0.51 | -3.9% | — | — | -13.3%$21.70→$18.82 |
| Q3 2025 | 2025-11-06 | -0.69 | -0.72 | +4.2% | — | — | +20.4%$19.31→$23.24 |
| Q1 2025 | 2025-05-12 | -0.92 | -0.79 | -16.5% | — | — | — |
| Q4 2024 | 2025-03-10 | -0.80 | -0.72 | -11.1% | — | — | — |
| Q2 2024 | 2024-08-13 | -0.91 | -0.83 | -9.6% | — | — | — |
| Q1 2024 | 2024-05-13 | -0.97 | -0.87 | -11.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.